ANTH:Anthera Pharmaceuticals Inc - Stock Price Quote and Dividend Data
LATEST CLOSE STOCK PRICE
$0.06
EXCHANGE
OTCBB
SECTOR
Health Care
ANTH
Anthera Pharmaceuticals Inc Dividend Information
Trailing 12 Month Dividend Yield0.00%
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Payment TypeNone
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid1970
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid1970
ANTH
Anthera Pharmaceuticals Inc Stock Price Information
Latest Close Stock Price$0.06
52-Week Low/High Stock Price$0.01 - $0.10
Percent Held by Institutions5.35%
Revenue$0
Net Income$-31,115,000
Cash Flow$-9,381,000
EPS-0.42%
Market Cap$1,544,561
52-Week Low/High Stock Price$0.01 - $0.10
Percent Held by Institutions5.35%
Revenue$0
Net Income$-31,115,000
Cash Flow$-9,381,000
EPS-0.42%
Market Cap$1,544,561
PE Ratio0
PE Ratio to Industry37%
Debt-Equity Ratio0.00%
Debt-Equity to Industry3.66%
Total Return Last 12 Months-18.06%
Total Return Last 3 Years-99.73%
Total Return Last 5 Years-99.60%
Latest Trade DateOct. 18, 2019
PE Ratio to Industry37%
Debt-Equity Ratio0.00%
Debt-Equity to Industry3.66%
Total Return Last 12 Months-18.06%
Total Return Last 3 Years-99.73%
Total Return Last 5 Years-99.60%
Latest Trade DateOct. 18, 2019
ANTH
Anthera Pharmaceuticals Inc Dividend Payment History
No Data available for Payment History.
ANTH
Anthera Pharmaceuticals Inc Other Details
Anthera Pharmaceuticals is a biopharmaceutical company focused on advancing the development and commercialization of medicines that benefit patients with medical needs. Co. has two compounds in development, Sollpura and blisibimod. Sollpura is a non-porcine investigational Pancreatic Enzyme Replacement Therapy intended for the treatment of patients with Exocrine Pancreatic Insufficiency, often seen in patients with cystic fibrosis and other conditions. Blisibimod targets B-cell activating factor, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy.
Web Sitewww.anthera.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools
Try Dividend Investor PREMIUM for as low as $29
- Dividend Allstars™ Tool
- Proprietary Ex-dividend Calendar
- Dividend Scorecard™ Portfolio Tracker
- Customized Dividend Stock Screener
- 4 FREE special reports from leading dividend experts
- And much more...
Anthera Pharmaceuticals Inc Dividend Stock News and Updates
Oct. 16, 2019CLOSE PRICE INCREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 10-16-2019 increased close price > 10% from $0.05 to $0.06
Read more...Oct. 15, 2019CLOSE PRICE DECREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 10-15-2019 decreased close price > 10% from $0.06 to $0.05
Read more...Oct. 09, 2019CLOSE PRICE INCREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 10-09-2019 increased close price > 10% from $0.05 to $0.06
Read more...Biotechnology Dividend Stock News and Updates
Oct. 19, 2019CLOSE PRICE DECREASE: Rezolute Inc (OTCBB: RZLT) on 10-19-2019 decreased close price > 10% from $0.15 to $0.10
Read more...Oct. 19, 2019CLOSE PRICE DECREASE: Regenicin, Inc. (OTCBB: RGIN) on 10-19-2019 decreased close price > 10% from $0.02 to $0.01
Read more...Oct. 19, 2019CLOSE PRICE DECREASE: RepliCel Life Sciences Inc. (OTCBB: REPCF) on 10-19-2019 decreased close price > 10% from $0.22 to $0.18
Read more...